| 5-A-RU | 5-amino-6-d-ribitylaminouracil |
| 5-OE-RU | 5-(2-oxoethylideneamino)-6-d-ribitylaminouracil |
| APC | Antigen-presenting cell |
| BAL | Bronchoalveolar lavage |
| BCG | Bacillus Calmette–Guérin |
| CCR2 | C–C chemokine receptor type 2 |
| CFU | Colony-forming unit |
| CpG | Cytosine–phosphate–guanine (CpG oligonucleotide) |
| DC | Dendritic cell |
| DMSO | Dimethyl sulfoxide |
| dpi | Days post infection |
| dsRNA | Double-stranded RNA |
| EC50 | Half-maximal effective concentration |
| GC | Germinal centre |
| GM-CSF | Granulocyte–macrophage colony-stimulating factor |
| HA | Hemagglutinin |
| IAV | Influenza A virus |
| ICOS | Inducible T-cell co-stimulator |
| IFN | Interferon |
| IFNAR | Interferon-α/β receptor (type I interferon receptor) |
| Ig | Immunoglobulin |
| IL | Interleukin |
| Ki-67 | Marker of proliferation Ki-67 |
| LPS | Lipopolysaccharide |
| Ly6C | Lymphocyte antigen 6 complex, locus C |
| MAIT | Mucosal-associated invariant T (cell) |
| MG | Methylglyoxal |
| MHC | Major histocompatibility complex |
| mLN | Mediastinal lymph node |
| MR1 | MHC class I-related protein 1 |
| NHP | Non-human primate |
| NK | Natural killer (cell) |
| NOS2 | Nitric oxide synthase 2 |
| OVA | Ovalbumin |
| Pam2CSK4 | Pam2Cys-Ser-(Lys)4 (synthetic TLR2/6 agonist) |
| Pam2Cys | S-[2,3-bis(palmitoyloxy)propyl]-l-cysteine |
| PAMP | Pathogen-associated molecular pattern |
| PBS | Phosphate-buffered saline |
| PD-1 | Programmed cell death protein 1 |
| polyI:C | Polyinosinic–polycytidylic acid |
| RORγt | Retinoic acid receptor-related orphan receptor gamma t |
| rVSV | Recombinant vesicular stomatitis virus |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| TB | Tuberculosis |
| T-bet | T-box expressed in T cells (TBX21) |
| TCR | T cell receptor |
| TFH | T follicular helper (cell) |
| Th | T helper (cell) |
| TLR | Toll-like receptor |
| TNF | Tumour necrosis factor |